---
title: 2nd quarter and first half 2018 report
description: 2nd quarter and first half 2018 report
---

<https://www.gentian.com/investor-relations-stock-information/investors-news>

# [2nd quarter and first half 2018 report](https://www.gentian.com/investor-relations-stock-information/investors-news/20252-2)

 Written by [Kristin Hart](https://www.gentian.com/investor-relations-stock-information/investors-news/author/kristin-hart) | Aug 14, 2019 8:00:00 PM

Moss 14.08.19

Gentian Diagnostics AS announces its results for the second quarter and first half of 2019.

The highlights include:

- 16 % growth in sales revenue in 2Q19 compared to 2Q18
- Total sales revenues of MNOK 10.2 in 2Q19, up from MNOK 8.8 in 2Q18
- FDA 510(k) clearance for the BÜHLMANN fCAL® turbo and with this access to the US market
- In July, Beckman Coulter, one of the top 5 global diagnostics companies, and Gentian have prolongated the trusted partnership agreement by another 6 years
- In August, Gentian announced the sales channel agreement for fCAL® turbo between Roche Diagnostics and Gentian’s sales partner Bühlmann Laboratories AG

Please find the report and results presentation here:

[GDAS 2019 1H interim report](https://www.gentian.com/hubfs/GDAS-2019-1H-interim-report.pdf)

[GDAS 2019 1H interim presentation](https://gentian.com/wp-content/uploads/2019/08/GDAS-2019-1H-interim-presentation.pdf)

 

**For further information, please contact: **

Hilja Ibert  
CEO, Gentian Diagnostics  
E-mail: [hilja.ibert@gentian.no](mailto:hilja.ibert@gentian.no)  
Cell Phone: +47 919 05 242

Njaal Kind  
CFO, Gentian Diagnostics  
E-mail: [njaal.kind@gentian.no](mailto:njaal.kind@gentian.no)  
Cell Phone: +47 919 06 525

 

**MeldingsID:** 482896

[View full post](https://www.gentian.com/investor-relations-stock-information/investors-news/20252-2)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Kristin Hart"
  },
  "dateModified" : "2019-12-10T12:32:10.748Z",
  "datePublished" : "2019-08-14T20:00:00Z",
  "headline" : "2nd quarter and first half 2018 report",
  "image" : {
    "@type" : "ImageObject",
    "height" : 60,
    "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
    "width" : 60
  },
  "mainEntityOfPage" : "https://www.gentian.com/investor-relations-stock-information/investors-news/20252-2",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Investor News"
  }
}
```